SLC26A9 and cystic fibrosis: In addition, two diffuse idiopathic bronchiectasis-related missense mutations (R575W and V486I) were reported to decrease Cl– transport, suggesting a potential role for SLC26A9 in treating cystic fibrosis-like diseases19.